Félix Gutiérrez

Universitat de Miguel Hernández d'Elx — Spain

Immunology and Microbiology · Life Sciences

55h-index15.9kcitations447works2.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV Research and Treatment(128), HIV/AIDS drug development and treatment(126), HIV-related health complications and treatments(117), HIV/AIDS Research and Interventions(113), Pneumocystis jirovecii pneumonia detection and treatment(35)

Publications420 total

Association Between Excessive Alcohol Consumption When Starting Antiretroviral Therapy and Long-term Mortality in People Living With HIV
Journal of Addiction Medicine·2025
Impact of Gluteal Injection Site on Pharmacokinetics and Tolerability of Antiretroviral Therapy with Long-Acting Cabotegravir and Rilpivirine
AIDS Patient Care and STDs·2025
Virological Success With Long-Acting Cabotegravir and Rilpivirine Despite Historical Rilpivirine Resistance: A Real-World Case Series
Open Forum Infectious Diseases·2025Open Access
Unveiling altered CD8 T-cell metabolism and homeostatic proliferation behind a low CD4/CD8 ratio in ART-suppressed HIV individuals with normal CD4 recovery
Frontiers in Immunology·2025Open Access
A decade of anal cancer screening in the context of HIV care
AIDS·2025
<scp>ADAR1 mRNA</scp> quantification for predicting <scp>HSIL</scp> in persons with <scp>HIV</scp> and abnormal anal cytology
International Journal of Cancer·2025· 1 citedOpen Access
Impact of the initial administration of an antiretroviral drug with latency reversal properties on the HIV reservoir size
Scientific Reports·2025· 3 citedOpen Access
Gut microbiota and weight gain in people with HIV on integrase inhibitors: a five-year longitudinal study
Journal of Antimicrobial Chemotherapy·2025· 1 citedOpen Access
Influence of patient characteristics and oral lead-in on long-acting cabotegravir and rilpivirine pharmacokinetics and outcomes in people with HIV: a real-world study
Antimicrobial Agents and Chemotherapy·2025· 2 citedOpen Access
Low-level viremia linked to virological failure but not clinical events
AIDS·2025
Markers of Inflammation and Immune Dysfunction and Non-AIDS Cancer Risk in Adults With HIV
JAIDS Journal of Acquired Immune Deficiency Syndromes·2025· 1 cited
Enhanced prediction of thrombotic events in hospitalized COVID-19 patients with soluble thrombomodulin
PLoS ONE·2025· 3 citedOpen Access
Increased mortality and morbidity risk in people with early HIV care interruption in Spain
AIDS·2025
Impact of Switching to Long-Acting Injectable Cabotegravir Plus Rilpivirine on Rectal HIV-1 RNA Shedding and Implications for Transmission Risk
The Journal of Infectious Diseases·2025· 1 citedOpen Access
Lung cancer screening in people with HIV: A missed opportunity for better outcomes?
Enfermedades infecciosas y microbiologia clinica (English ed )·2025
La educación reinventada: Un compendio de prácticas innovadoras
2025Open Access
Lung cancer screening in people with HIV: A missed opportunity for better outcomes?
Enfermedades Infecciosas y Microbiología Clínica·2025
Ecos de libertad
2025
Long-term effectiveness and tolerability of dolutegravir/lamivudine in treatment-naive people with HIV: an analysis of a multicentre cohort at 96 weeks
Journal of Antimicrobial Chemotherapy·2024· 2 citedOpen Access
Insights on Drug Levels and Non-Sustained Viral Suppression With Long-Acting Cabotegravir and Rilpivirine Therapy
Clinical Infectious Diseases·2024· 2 cited
page 1 of 21Next →

Frequent Co-authors

Mar Masiá(23), Sergio Padilla(19), Juan Berenguer(10), José Manuel Ramos(9), Julia del Amo(8), Santiago Moreno(8), Pompeyo Viciana(7), Ildefonso Hernández‐Aguado(7), Christoph Stephan(7), José Antonio Iribarren(7), Enrique Bernal(7), Daniel Podzamczer(6), Juan Carlos Rodrı́guez(6), Antonella d’Arminio Monforte(6), Inmaculada Jarrín(6), Francesc Vidal(6), Vicente Estrada(5), Jens Lundgren(5), Jürgen K. Rockstroh(5), Estebán Martínez(5)